Latest filing published 16 Mar 2026 for ClearPoint Neuro, Inc..
Insider track record
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Mazin Sabra: trading record in brief
Mazin Sabra discloses dealings in ClearPoint Neuro, Inc. to SEC (Form 4). In total, 22 filings cover trades dated from 10 October 2022 to 12 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 16 March 2026 with a share grant (€133k) in ClearPoint Neuro, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mazin Sabra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 26,101 sharesCommon StockSEC:0001193125-26-108071:0
- 7,480 shares@ US$26.11Common StockSEC:0001193125-25-239059:0
- 361 shares@ US$10.152.4% of flowCommon StockSEC:0000950170-25-093170:0
- 13,050 sharesCommon StockSEC:0000950170-25-039521:0
- 13,827 sharesCommon StockSEC:0000950170-25-036673:0
- 784 shares@ US$4.532.7% of flowCommon StockSEC:0000950170-25-001339:0
- 7,465 shares@ US$11.3961.3% of flowCommon StockSEC:0001285550-24-000117:0
- 767 shares@ US$4.582.6% of flowCommon StockSEC:0001285550-24-000091:0
- 6,913 shares0Common StockSEC:0001285550-24-000026:0
- 590 shares@ US$5.772.4% of flowCommon StockSEC:0001285550-24-000013:0
- 7,603 shares@ US$5.0428.5% of flowCommon StockSEC:0001285550-23-000109:0
- 552 shares@ US$6.152.5% of flowCommon StockSEC:0001285550-23-000082:0
- 46,000 shares0Common StockSEC:0001285550-22-000069:0
13 of 13 declarations
